On the mechanisms underlying 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity. II. Susceptibility among mammalian species correlates with the toxin's metabolic patterns in brain microvessels and liver
Systemic 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) causes parkinsonism in humans and other primates, but not in rats; mice are intermediate in their susceptibility which varies among strains. We hypothesized previously that the rat's resistance to systemic MPTP toxicity is likely due...
محفوظ في:
| المؤلف الرئيسي: | Riachi, N.J. (author) |
|---|---|
| مؤلفون آخرون: | Harik, S.I. (author), Kalaria, R.N. (author), Sayre, L.M. (author) |
| التنسيق: | article |
| منشور في: |
1988
|
| الوصول للمادة أونلاين: | http://hdl.handle.net/10725/10442 http://libraries.lau.edu.lb/research/laur/terms-of-use/articles.php http://jpet.aspetjournals.org/content/244/2/443.short |
| الوسوم: |
إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|
مواد مشابهة
-
Entry of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine into the rat brain
حسب: Riachi, N.J.
منشور في: (1989) -
Potent neurotoxic fluorinated 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine analogs as potential probes in models of parkinson disease
حسب: Riachi, Naji J.
منشور في: (1988) -
Strain differences in systematic 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity in mice correlate best with monoamine oxidase activity at the blood-brain barrier
حسب: Riachi, Naji J.
منشور في: (1988) -
Development of fluorinated 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine analogs with potent nigrostriatal toxicity for potential use in positron emission tomography studies
حسب: Riachi, N.J.
منشور في: (1993) -
Chemical oxidation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and its in vivo metabolism in rat brain and liver
حسب: Riachi, Naji J.
منشور في: (1988)